ALEBUND-B

9637
20.1002.43% ( -0.500 )
Delay Closed: Nov 16, 16:08:11

Profile

About

ALEBUND-B
ALEBUND-B
09637.HK

Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong. Its products include AP301, a phosphate binder; AP306, a sodium-dependent phosphate transport protein inhibitor; one early-clinical-stage product candidate AP303; and four preclinical product candidates, including AP308, AP304, AP305, and AP307. Alebund Pharmaceuticals (Jiangsu) Limited was founded in 2018 and is headquartered in Yangzhou, China.

Profile

Company Name
Alebund Pharmaceuticals (Jiangsu) Limited
Market
SEHK
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management